Skip to main content

Table 1 Baseline characteristics of the 23 patients with severe drug-induced hepatotoxicity

From: Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

  Patients who stopped anti-TB drugs and received hepatoprotective drugs (N = 17) Patients who stopped anti-TB drugs but did not receive hepatoprotective drugs (N = 6) P value
Sex    1.00
 Male 12 4  
 Female 5 2  
Age, years 64 ± 20 58 ± 22 0.58
Peak AST (IU/dl) 477 ± 404 278 ± 156 0.31
Peak ALT (IU/dl) 362 ± 188 262 ± 132 0.55
  1. Data are expressed as number or means ± standard error
  2. TB tuberculosis, AST aspartate aminotransferase, ALT alanine aminotransferase